About lifespin®

lifespin is a pioneering, cross-disciplinary technology company merging NMR, metabolomics and AI to enable a new paradigm of healthcare that is personalized and equitable.

Meet the brilliant minds driving our team

To enable proactive, precise, continuous healthcare for all

Building the metabolomic digital twin for precision medicine

Who we are:

lifespin is a pioneering, cross-disciplinary technology company merging NMR, metabolomics and AI to enable a new paradigm of healthcare that is personalized and equitable.

Positioning:

Our AI-driven metabolomics platform provides healthcare professionals with a scalable and sustainable way to deliver affordable precision healthcare utilizing the data captured by digital twinning from blood samples.

Opportunity:

The initial expenses associated with today’s precision health are often prohibitively high for the majority of the global population. At lifespin, we have taken this affordability challenge into account right from the beginning. Our platform eliminates the need for tedious lab tests, requiring only a basic NMR instrument to produce results.Coupled with our exclusive database housing more than 240,000+ human metabolome profiles and our AI-powered software, we provide rapid, high-resolution, comprehensive, and personalized health insights at truly disruptive cost.

Our Mission:

To drive a deep health approach to global healthcare by creating digital twins based on metabolomic profiles for prevention, diagnosis and therapy.

Team with industry leading expertise

Excellence in science, technology and business

lifespin leadership

A team with industry leading expertise

Dr. Ali Tinazli

CEO

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

Dr. Fritz Huber

CEO & Co-Founder

20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Renate Kirchhöfer

CDO & Co-Founder

20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Roland Geyer

COO

10+ years experience in NMR-based metabolomics and diagnostic.

Advisory board

Expert guidance for strategic decisions

Prof. Dr. James Rothman

Sterling-Professor of Cell Biology , Yale University, Nobel Laureate for Physiology / Medicine

Nobel Laureate Physiology/ Medicine 2013

Dr. Trevor Hawkins

Seasoned Senior Executive & Industry Veteran in Diagnostics

Previously Director of the Human Genome Project for the US.DOE, and held senior executive roles at Siemens Healthcare, Philips, GE Healthcare and Amersham.

Prof. Dr. Felix Wieland

Senior Professor for Biochemistry Heidelberg University

Prof. Wieland is an elected Member of the Academia Europea and the National Academy of Sciences, Leopoldina, as well as an Honorary member of the Charité.

Lead investor

The visionaries behind our lead investment

Robert Wieland

Managing Director
Wieland Capital

Focus on healthcare investments. Prior to founding Wieland Capital, Mr. Wieland was in the M&A department at Credit Suisse First Boston (CSFB) and Donaldson, Lufkin & Jenrette (DLJ) in London.

From bavaria to the world

The collaborations with our partners span the globe

lifespin’s network of clinical partners

Collaborative excellence for groundbreaking health solutions

Contact us for more information for partnering and investment opportunities, alternatively, explore the comprehensive list of benefits

Scroll to Top

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.